We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Check the tariff classification for a heat and moisture exchanging filter.
Product Safety Report for Kojic Clear lotion with Papaya presenting a chemical risk.
Product Safety Report for Skin Gard Lightening Lotion presenting a serious chemical risk.
Product Safety Report for Anise Shealight Fading Cream Face & Body presenting a serious chemical risk.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Product Safety Report for Purec Egyptian Magic Whitening Face and Body Lotion presenting a serious chemical risk due to the presence of hydroquinone and glucocorticoids.
Product Safety Report for White Express Lightening Body Lotion presenting a serious chemical risk.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Product Safety Report for SWP+ Skin Whitening Body Lotion presenting a serious chemical risk.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
The management, surveillance and epidemiology of carbapenem resistance.
Check the tariff classification for flavour pods.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Information to support your recovery after COVID-19.
Check the tariff classification for peptide nisin standardised with sodium chloride
Product recall for Firming Cream presenting a serious chemical risk.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.